Global Anti-androgen Drugs Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Anti-androgen Drugs market size was valued at US$ 7818 million in 2025 and is forecast to a readjusted size of US$ 17964 million by 2032 with a CAGR of 12.2% during review period.
Anti-androgen drugs are a class of therapeutics that inhibit androgen production, block androgen receptor (AR) signaling, or interfere with downstream androgen pathways, primarily used to treat androgen-dependent diseases, with prostate cancer as the core indication, while also covering conditions such as polycystic ovary syndrome (PCOS), hirsutism, and gender-affirming hormone therapy; the category includes non-steroidal AR inhibitors (e.g., Enzalutamide, Apalutamide, Darolutamide), steroidal anti-androgens (e.g., Cyproterone Acetate), and androgen biosynthesis inhibitors (e.g., Abiraterone Acetate), forming a comprehensive market characterized by mechanistic diversity and indication-driven demand.
This report is a detailed and comprehensive analysis for global Anti-androgen Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Anti-androgen Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Anti-androgen Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Anti-androgen Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Anti-androgen Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Anti-androgen Drugs market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Anti-androgen Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Anti-androgen Drugs, with price, sales quantity, revenue, and global market share of Anti-androgen Drugs from 2021 to 2026.
Chapter 3, the Anti-androgen Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-androgen Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Anti-androgen Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Anti-androgen Drugs.
Chapter 14 and 15, to describe Anti-androgen Drugs sales channel, distributors, customers, research findings and conclusion.
Anti-androgen drugs are a class of therapeutics that inhibit androgen production, block androgen receptor (AR) signaling, or interfere with downstream androgen pathways, primarily used to treat androgen-dependent diseases, with prostate cancer as the core indication, while also covering conditions such as polycystic ovary syndrome (PCOS), hirsutism, and gender-affirming hormone therapy; the category includes non-steroidal AR inhibitors (e.g., Enzalutamide, Apalutamide, Darolutamide), steroidal anti-androgens (e.g., Cyproterone Acetate), and androgen biosynthesis inhibitors (e.g., Abiraterone Acetate), forming a comprehensive market characterized by mechanistic diversity and indication-driven demand.
This report is a detailed and comprehensive analysis for global Anti-androgen Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Anti-androgen Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Anti-androgen Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Anti-androgen Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Anti-androgen Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Anti-androgen Drugs
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Anti-androgen Drugs market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- NSARIs
- SARIs
- ASIs
- 1st Gen
- 2nd Gen
- nmCRPC
- mCRPC
- mHSPC
- Special Endocrine / Female
- Astellas
- Pfizer
- Johnson & Johnson
- Bayer AG
- Orion
- Teva Pharmaceutical
- Sun Pharmaceutical
- Dr. Reddy's Laboratories
- Cipla
- Hengrui Pharmaceuticals
- Lonza Group
- WuXi AppTec
- Asymchem Laboratories
- Catalent
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Anti-androgen Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Anti-androgen Drugs, with price, sales quantity, revenue, and global market share of Anti-androgen Drugs from 2021 to 2026.
Chapter 3, the Anti-androgen Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-androgen Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Anti-androgen Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Anti-androgen Drugs.
Chapter 14 and 15, to describe Anti-androgen Drugs sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Anti-androgen Drugs Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 NSARIs
1.3.3 SARIs
1.3.4 ASIs
1.4 Market Analysis by Generation
1.4.1 Overview: Global Anti-androgen Drugs Consumption Value by Generation: 2021 Versus 2025 Versus 2032
1.4.2 1st Gen
1.4.3 2nd Gen
1.5 Market Analysis by Application
1.5.1 Overview: Global Anti-androgen Drugs Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.5.2 nmCRPC
1.5.3 mCRPC
1.5.4 mHSPC
1.5.5 Special Endocrine / Female
1.6 Global Anti-androgen Drugs Market Size & Forecast
1.6.1 Global Anti-androgen Drugs Consumption Value (2021 & 2025 & 2032)
1.6.2 Global Anti-androgen Drugs Sales Quantity (2021-2032)
1.6.3 Global Anti-androgen Drugs Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Astellas
2.1.1 Astellas Details
2.1.2 Astellas Major Business
2.1.3 Astellas Anti-androgen Drugs Product and Services
2.1.4 Astellas Anti-androgen Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Astellas Recent Developments/Updates
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Anti-androgen Drugs Product and Services
2.2.4 Pfizer Anti-androgen Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Pfizer Recent Developments/Updates
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Anti-androgen Drugs Product and Services
2.3.4 Johnson & Johnson Anti-androgen Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Johnson & Johnson Recent Developments/Updates
2.4 Bayer AG
2.4.1 Bayer AG Details
2.4.2 Bayer AG Major Business
2.4.3 Bayer AG Anti-androgen Drugs Product and Services
2.4.4 Bayer AG Anti-androgen Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Bayer AG Recent Developments/Updates
2.5 Orion
2.5.1 Orion Details
2.5.2 Orion Major Business
2.5.3 Orion Anti-androgen Drugs Product and Services
2.5.4 Orion Anti-androgen Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Orion Recent Developments/Updates
2.6 Teva Pharmaceutical
2.6.1 Teva Pharmaceutical Details
2.6.2 Teva Pharmaceutical Major Business
2.6.3 Teva Pharmaceutical Anti-androgen Drugs Product and Services
2.6.4 Teva Pharmaceutical Anti-androgen Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Teva Pharmaceutical Recent Developments/Updates
2.7 Sun Pharmaceutical
2.7.1 Sun Pharmaceutical Details
2.7.2 Sun Pharmaceutical Major Business
2.7.3 Sun Pharmaceutical Anti-androgen Drugs Product and Services
2.7.4 Sun Pharmaceutical Anti-androgen Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Sun Pharmaceutical Recent Developments/Updates
2.8 Dr. Reddy's Laboratories
2.8.1 Dr. Reddy's Laboratories Details
2.8.2 Dr. Reddy's Laboratories Major Business
2.8.3 Dr. Reddy's Laboratories Anti-androgen Drugs Product and Services
2.8.4 Dr. Reddy's Laboratories Anti-androgen Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Dr. Reddy's Laboratories Recent Developments/Updates
2.9 Cipla
2.9.1 Cipla Details
2.9.2 Cipla Major Business
2.9.3 Cipla Anti-androgen Drugs Product and Services
2.9.4 Cipla Anti-androgen Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Cipla Recent Developments/Updates
2.10 Hengrui Pharmaceuticals
2.10.1 Hengrui Pharmaceuticals Details
2.10.2 Hengrui Pharmaceuticals Major Business
2.10.3 Hengrui Pharmaceuticals Anti-androgen Drugs Product and Services
2.10.4 Hengrui Pharmaceuticals Anti-androgen Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Hengrui Pharmaceuticals Recent Developments/Updates
2.11 Lonza Group
2.11.1 Lonza Group Details
2.11.2 Lonza Group Major Business
2.11.3 Lonza Group Anti-androgen Drugs Product and Services
2.11.4 Lonza Group Anti-androgen Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Lonza Group Recent Developments/Updates
2.12 WuXi AppTec
2.12.1 WuXi AppTec Details
2.12.2 WuXi AppTec Major Business
2.12.3 WuXi AppTec Anti-androgen Drugs Product and Services
2.12.4 WuXi AppTec Anti-androgen Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 WuXi AppTec Recent Developments/Updates
2.13 Asymchem Laboratories
2.13.1 Asymchem Laboratories Details
2.13.2 Asymchem Laboratories Major Business
2.13.3 Asymchem Laboratories Anti-androgen Drugs Product and Services
2.13.4 Asymchem Laboratories Anti-androgen Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Asymchem Laboratories Recent Developments/Updates
2.14 Catalent
2.14.1 Catalent Details
2.14.2 Catalent Major Business
2.14.3 Catalent Anti-androgen Drugs Product and Services
2.14.4 Catalent Anti-androgen Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Catalent Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ANTI-ANDROGEN DRUGS BY MANUFACTURER
3.1 Global Anti-androgen Drugs Sales Quantity by Manufacturer (2021-2026)
3.2 Global Anti-androgen Drugs Revenue by Manufacturer (2021-2026)
3.3 Global Anti-androgen Drugs Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Anti-androgen Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Anti-androgen Drugs Manufacturer Market Share in 2025
3.4.3 Top 6 Anti-androgen Drugs Manufacturer Market Share in 2025
3.5 Anti-androgen Drugs Market: Overall Company Footprint Analysis
3.5.1 Anti-androgen Drugs Market: Region Footprint
3.5.2 Anti-androgen Drugs Market: Company Product Type Footprint
3.5.3 Anti-androgen Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Anti-androgen Drugs Market Size by Region
4.1.1 Global Anti-androgen Drugs Sales Quantity by Region (2021-2032)
4.1.2 Global Anti-androgen Drugs Consumption Value by Region (2021-2032)
4.1.3 Global Anti-androgen Drugs Average Price by Region (2021-2032)
4.2 North America Anti-androgen Drugs Consumption Value (2021-2032)
4.3 Europe Anti-androgen Drugs Consumption Value (2021-2032)
4.4 Asia-Pacific Anti-androgen Drugs Consumption Value (2021-2032)
4.5 South America Anti-androgen Drugs Consumption Value (2021-2032)
4.6 Middle East & Africa Anti-androgen Drugs Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Anti-androgen Drugs Sales Quantity by Type (2021-2032)
5.2 Global Anti-androgen Drugs Consumption Value by Type (2021-2032)
5.3 Global Anti-androgen Drugs Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Anti-androgen Drugs Sales Quantity by Application (2021-2032)
6.2 Global Anti-androgen Drugs Consumption Value by Application (2021-2032)
6.3 Global Anti-androgen Drugs Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Anti-androgen Drugs Sales Quantity by Type (2021-2032)
7.2 North America Anti-androgen Drugs Sales Quantity by Application (2021-2032)
7.3 North America Anti-androgen Drugs Market Size by Country
7.3.1 North America Anti-androgen Drugs Sales Quantity by Country (2021-2032)
7.3.2 North America Anti-androgen Drugs Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Anti-androgen Drugs Sales Quantity by Type (2021-2032)
8.2 Europe Anti-androgen Drugs Sales Quantity by Application (2021-2032)
8.3 Europe Anti-androgen Drugs Market Size by Country
8.3.1 Europe Anti-androgen Drugs Sales Quantity by Country (2021-2032)
8.3.2 Europe Anti-androgen Drugs Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Anti-androgen Drugs Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Anti-androgen Drugs Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Anti-androgen Drugs Market Size by Region
9.3.1 Asia-Pacific Anti-androgen Drugs Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Anti-androgen Drugs Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Anti-androgen Drugs Sales Quantity by Type (2021-2032)
10.2 South America Anti-androgen Drugs Sales Quantity by Application (2021-2032)
10.3 South America Anti-androgen Drugs Market Size by Country
10.3.1 South America Anti-androgen Drugs Sales Quantity by Country (2021-2032)
10.3.2 South America Anti-androgen Drugs Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Anti-androgen Drugs Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Anti-androgen Drugs Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Anti-androgen Drugs Market Size by Country
11.3.1 Middle East & Africa Anti-androgen Drugs Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Anti-androgen Drugs Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Anti-androgen Drugs Market Drivers
12.2 Anti-androgen Drugs Market Restraints
12.3 Anti-androgen Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Anti-androgen Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Anti-androgen Drugs
13.3 Anti-androgen Drugs Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Anti-androgen Drugs Typical Distributors
14.3 Anti-androgen Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Anti-androgen Drugs Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 NSARIs
1.3.3 SARIs
1.3.4 ASIs
1.4 Market Analysis by Generation
1.4.1 Overview: Global Anti-androgen Drugs Consumption Value by Generation: 2021 Versus 2025 Versus 2032
1.4.2 1st Gen
1.4.3 2nd Gen
1.5 Market Analysis by Application
1.5.1 Overview: Global Anti-androgen Drugs Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.5.2 nmCRPC
1.5.3 mCRPC
1.5.4 mHSPC
1.5.5 Special Endocrine / Female
1.6 Global Anti-androgen Drugs Market Size & Forecast
1.6.1 Global Anti-androgen Drugs Consumption Value (2021 & 2025 & 2032)
1.6.2 Global Anti-androgen Drugs Sales Quantity (2021-2032)
1.6.3 Global Anti-androgen Drugs Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Astellas
2.1.1 Astellas Details
2.1.2 Astellas Major Business
2.1.3 Astellas Anti-androgen Drugs Product and Services
2.1.4 Astellas Anti-androgen Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Astellas Recent Developments/Updates
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Anti-androgen Drugs Product and Services
2.2.4 Pfizer Anti-androgen Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Pfizer Recent Developments/Updates
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Anti-androgen Drugs Product and Services
2.3.4 Johnson & Johnson Anti-androgen Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Johnson & Johnson Recent Developments/Updates
2.4 Bayer AG
2.4.1 Bayer AG Details
2.4.2 Bayer AG Major Business
2.4.3 Bayer AG Anti-androgen Drugs Product and Services
2.4.4 Bayer AG Anti-androgen Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Bayer AG Recent Developments/Updates
2.5 Orion
2.5.1 Orion Details
2.5.2 Orion Major Business
2.5.3 Orion Anti-androgen Drugs Product and Services
2.5.4 Orion Anti-androgen Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Orion Recent Developments/Updates
2.6 Teva Pharmaceutical
2.6.1 Teva Pharmaceutical Details
2.6.2 Teva Pharmaceutical Major Business
2.6.3 Teva Pharmaceutical Anti-androgen Drugs Product and Services
2.6.4 Teva Pharmaceutical Anti-androgen Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Teva Pharmaceutical Recent Developments/Updates
2.7 Sun Pharmaceutical
2.7.1 Sun Pharmaceutical Details
2.7.2 Sun Pharmaceutical Major Business
2.7.3 Sun Pharmaceutical Anti-androgen Drugs Product and Services
2.7.4 Sun Pharmaceutical Anti-androgen Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Sun Pharmaceutical Recent Developments/Updates
2.8 Dr. Reddy's Laboratories
2.8.1 Dr. Reddy's Laboratories Details
2.8.2 Dr. Reddy's Laboratories Major Business
2.8.3 Dr. Reddy's Laboratories Anti-androgen Drugs Product and Services
2.8.4 Dr. Reddy's Laboratories Anti-androgen Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Dr. Reddy's Laboratories Recent Developments/Updates
2.9 Cipla
2.9.1 Cipla Details
2.9.2 Cipla Major Business
2.9.3 Cipla Anti-androgen Drugs Product and Services
2.9.4 Cipla Anti-androgen Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Cipla Recent Developments/Updates
2.10 Hengrui Pharmaceuticals
2.10.1 Hengrui Pharmaceuticals Details
2.10.2 Hengrui Pharmaceuticals Major Business
2.10.3 Hengrui Pharmaceuticals Anti-androgen Drugs Product and Services
2.10.4 Hengrui Pharmaceuticals Anti-androgen Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Hengrui Pharmaceuticals Recent Developments/Updates
2.11 Lonza Group
2.11.1 Lonza Group Details
2.11.2 Lonza Group Major Business
2.11.3 Lonza Group Anti-androgen Drugs Product and Services
2.11.4 Lonza Group Anti-androgen Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Lonza Group Recent Developments/Updates
2.12 WuXi AppTec
2.12.1 WuXi AppTec Details
2.12.2 WuXi AppTec Major Business
2.12.3 WuXi AppTec Anti-androgen Drugs Product and Services
2.12.4 WuXi AppTec Anti-androgen Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 WuXi AppTec Recent Developments/Updates
2.13 Asymchem Laboratories
2.13.1 Asymchem Laboratories Details
2.13.2 Asymchem Laboratories Major Business
2.13.3 Asymchem Laboratories Anti-androgen Drugs Product and Services
2.13.4 Asymchem Laboratories Anti-androgen Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Asymchem Laboratories Recent Developments/Updates
2.14 Catalent
2.14.1 Catalent Details
2.14.2 Catalent Major Business
2.14.3 Catalent Anti-androgen Drugs Product and Services
2.14.4 Catalent Anti-androgen Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Catalent Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ANTI-ANDROGEN DRUGS BY MANUFACTURER
3.1 Global Anti-androgen Drugs Sales Quantity by Manufacturer (2021-2026)
3.2 Global Anti-androgen Drugs Revenue by Manufacturer (2021-2026)
3.3 Global Anti-androgen Drugs Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Anti-androgen Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Anti-androgen Drugs Manufacturer Market Share in 2025
3.4.3 Top 6 Anti-androgen Drugs Manufacturer Market Share in 2025
3.5 Anti-androgen Drugs Market: Overall Company Footprint Analysis
3.5.1 Anti-androgen Drugs Market: Region Footprint
3.5.2 Anti-androgen Drugs Market: Company Product Type Footprint
3.5.3 Anti-androgen Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Anti-androgen Drugs Market Size by Region
4.1.1 Global Anti-androgen Drugs Sales Quantity by Region (2021-2032)
4.1.2 Global Anti-androgen Drugs Consumption Value by Region (2021-2032)
4.1.3 Global Anti-androgen Drugs Average Price by Region (2021-2032)
4.2 North America Anti-androgen Drugs Consumption Value (2021-2032)
4.3 Europe Anti-androgen Drugs Consumption Value (2021-2032)
4.4 Asia-Pacific Anti-androgen Drugs Consumption Value (2021-2032)
4.5 South America Anti-androgen Drugs Consumption Value (2021-2032)
4.6 Middle East & Africa Anti-androgen Drugs Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Anti-androgen Drugs Sales Quantity by Type (2021-2032)
5.2 Global Anti-androgen Drugs Consumption Value by Type (2021-2032)
5.3 Global Anti-androgen Drugs Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Anti-androgen Drugs Sales Quantity by Application (2021-2032)
6.2 Global Anti-androgen Drugs Consumption Value by Application (2021-2032)
6.3 Global Anti-androgen Drugs Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Anti-androgen Drugs Sales Quantity by Type (2021-2032)
7.2 North America Anti-androgen Drugs Sales Quantity by Application (2021-2032)
7.3 North America Anti-androgen Drugs Market Size by Country
7.3.1 North America Anti-androgen Drugs Sales Quantity by Country (2021-2032)
7.3.2 North America Anti-androgen Drugs Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Anti-androgen Drugs Sales Quantity by Type (2021-2032)
8.2 Europe Anti-androgen Drugs Sales Quantity by Application (2021-2032)
8.3 Europe Anti-androgen Drugs Market Size by Country
8.3.1 Europe Anti-androgen Drugs Sales Quantity by Country (2021-2032)
8.3.2 Europe Anti-androgen Drugs Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Anti-androgen Drugs Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Anti-androgen Drugs Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Anti-androgen Drugs Market Size by Region
9.3.1 Asia-Pacific Anti-androgen Drugs Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Anti-androgen Drugs Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Anti-androgen Drugs Sales Quantity by Type (2021-2032)
10.2 South America Anti-androgen Drugs Sales Quantity by Application (2021-2032)
10.3 South America Anti-androgen Drugs Market Size by Country
10.3.1 South America Anti-androgen Drugs Sales Quantity by Country (2021-2032)
10.3.2 South America Anti-androgen Drugs Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Anti-androgen Drugs Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Anti-androgen Drugs Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Anti-androgen Drugs Market Size by Country
11.3.1 Middle East & Africa Anti-androgen Drugs Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Anti-androgen Drugs Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Anti-androgen Drugs Market Drivers
12.2 Anti-androgen Drugs Market Restraints
12.3 Anti-androgen Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Anti-androgen Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Anti-androgen Drugs
13.3 Anti-androgen Drugs Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Anti-androgen Drugs Typical Distributors
14.3 Anti-androgen Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Anti-androgen Drugs Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Anti-androgen Drugs Consumption Value by Generation, (USD Million), 2021 & 2025 & 2032
Table 3. Global Anti-androgen Drugs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 4. Astellas Basic Information, Manufacturing Base and Competitors
Table 5. Astellas Major Business
Table 6. Astellas Anti-androgen Drugs Product and Services
Table 7. Astellas Anti-androgen Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 8. Astellas Recent Developments/Updates
Table 9. Pfizer Basic Information, Manufacturing Base and Competitors
Table 10. Pfizer Major Business
Table 11. Pfizer Anti-androgen Drugs Product and Services
Table 12. Pfizer Anti-androgen Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 13. Pfizer Recent Developments/Updates
Table 14. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 15. Johnson & Johnson Major Business
Table 16. Johnson & Johnson Anti-androgen Drugs Product and Services
Table 17. Johnson & Johnson Anti-androgen Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 18. Johnson & Johnson Recent Developments/Updates
Table 19. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 20. Bayer AG Major Business
Table 21. Bayer AG Anti-androgen Drugs Product and Services
Table 22. Bayer AG Anti-androgen Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. Bayer AG Recent Developments/Updates
Table 24. Orion Basic Information, Manufacturing Base and Competitors
Table 25. Orion Major Business
Table 26. Orion Anti-androgen Drugs Product and Services
Table 27. Orion Anti-androgen Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Orion Recent Developments/Updates
Table 29. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 30. Teva Pharmaceutical Major Business
Table 31. Teva Pharmaceutical Anti-androgen Drugs Product and Services
Table 32. Teva Pharmaceutical Anti-androgen Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. Teva Pharmaceutical Recent Developments/Updates
Table 34. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 35. Sun Pharmaceutical Major Business
Table 36. Sun Pharmaceutical Anti-androgen Drugs Product and Services
Table 37. Sun Pharmaceutical Anti-androgen Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Sun Pharmaceutical Recent Developments/Updates
Table 39. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 40. Dr. Reddy's Laboratories Major Business
Table 41. Dr. Reddy's Laboratories Anti-androgen Drugs Product and Services
Table 42. Dr. Reddy's Laboratories Anti-androgen Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Dr. Reddy's Laboratories Recent Developments/Updates
Table 44. Cipla Basic Information, Manufacturing Base and Competitors
Table 45. Cipla Major Business
Table 46. Cipla Anti-androgen Drugs Product and Services
Table 47. Cipla Anti-androgen Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. Cipla Recent Developments/Updates
Table 49. Hengrui Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 50. Hengrui Pharmaceuticals Major Business
Table 51. Hengrui Pharmaceuticals Anti-androgen Drugs Product and Services
Table 52. Hengrui Pharmaceuticals Anti-androgen Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. Hengrui Pharmaceuticals Recent Developments/Updates
Table 54. Lonza Group Basic Information, Manufacturing Base and Competitors
Table 55. Lonza Group Major Business
Table 56. Lonza Group Anti-androgen Drugs Product and Services
Table 57. Lonza Group Anti-androgen Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 58. Lonza Group Recent Developments/Updates
Table 59. WuXi AppTec Basic Information, Manufacturing Base and Competitors
Table 60. WuXi AppTec Major Business
Table 61. WuXi AppTec Anti-androgen Drugs Product and Services
Table 62. WuXi AppTec Anti-androgen Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 63. WuXi AppTec Recent Developments/Updates
Table 64. Asymchem Laboratories Basic Information, Manufacturing Base and Competitors
Table 65. Asymchem Laboratories Major Business
Table 66. Asymchem Laboratories Anti-androgen Drugs Product and Services
Table 67. Asymchem Laboratories Anti-androgen Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 68. Asymchem Laboratories Recent Developments/Updates
Table 69. Catalent Basic Information, Manufacturing Base and Competitors
Table 70. Catalent Major Business
Table 71. Catalent Anti-androgen Drugs Product and Services
Table 72. Catalent Anti-androgen Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 73. Catalent Recent Developments/Updates
Table 74. Global Anti-androgen Drugs Sales Quantity by Manufacturer (2021-2026) & (K Dose)
Table 75. Global Anti-androgen Drugs Revenue by Manufacturer (2021-2026) & (USD Million)
Table 76. Global Anti-androgen Drugs Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 77. Market Position of Manufacturers in Anti-androgen Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 78. Head Office and Anti-androgen Drugs Production Site of Key Manufacturer
Table 79. Anti-androgen Drugs Market: Company Product Type Footprint
Table 80. Anti-androgen Drugs Market: Company Product Application Footprint
Table 81. Anti-androgen Drugs New Market Entrants and Barriers to Market Entry
Table 82. Anti-androgen Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 83. Global Anti-androgen Drugs Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 84. Global Anti-androgen Drugs Sales Quantity by Region (2021-2026) & (K Dose)
Table 85. Global Anti-androgen Drugs Sales Quantity by Region (2027-2032) & (K Dose)
Table 86. Global Anti-androgen Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 87. Global Anti-androgen Drugs Consumption Value by Region (2027-2032) & (USD Million)
Table 88. Global Anti-androgen Drugs Average Price by Region (2021-2026) & (US$/Dose)
Table 89. Global Anti-androgen Drugs Average Price by Region (2027-2032) & (US$/Dose)
Table 90. Global Anti-androgen Drugs Sales Quantity by Type (2021-2026) & (K Dose)
Table 91. Global Anti-androgen Drugs Sales Quantity by Type (2027-2032) & (K Dose)
Table 92. Global Anti-androgen Drugs Consumption Value by Type (2021-2026) & (USD Million)
Table 93. Global Anti-androgen Drugs Consumption Value by Type (2027-2032) & (USD Million)
Table 94. Global Anti-androgen Drugs Average Price by Type (2021-2026) & (US$/Dose)
Table 95. Global Anti-androgen Drugs Average Price by Type (2027-2032) & (US$/Dose)
Table 96. Global Anti-androgen Drugs Sales Quantity by Application (2021-2026) & (K Dose)
Table 97. Global Anti-androgen Drugs Sales Quantity by Application (2027-2032) & (K Dose)
Table 98. Global Anti-androgen Drugs Consumption Value by Application (2021-2026) & (USD Million)
Table 99. Global Anti-androgen Drugs Consumption Value by Application (2027-2032) & (USD Million)
Table 100. Global Anti-androgen Drugs Average Price by Application (2021-2026) & (US$/Dose)
Table 101. Global Anti-androgen Drugs Average Price by Application (2027-2032) & (US$/Dose)
Table 102. North America Anti-androgen Drugs Sales Quantity by Type (2021-2026) & (K Dose)
Table 103. North America Anti-androgen Drugs Sales Quantity by Type (2027-2032) & (K Dose)
Table 104. North America Anti-androgen Drugs Sales Quantity by Application (2021-2026) & (K Dose)
Table 105. North America Anti-androgen Drugs Sales Quantity by Application (2027-2032) & (K Dose)
Table 106. North America Anti-androgen Drugs Sales Quantity by Country (2021-2026) & (K Dose)
Table 107. North America Anti-androgen Drugs Sales Quantity by Country (2027-2032) & (K Dose)
Table 108. North America Anti-androgen Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 109. North America Anti-androgen Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 110. Europe Anti-androgen Drugs Sales Quantity by Type (2021-2026) & (K Dose)
Table 111. Europe Anti-androgen Drugs Sales Quantity by Type (2027-2032) & (K Dose)
Table 112. Europe Anti-androgen Drugs Sales Quantity by Application (2021-2026) & (K Dose)
Table 113. Europe Anti-androgen Drugs Sales Quantity by Application (2027-2032) & (K Dose)
Table 114. Europe Anti-androgen Drugs Sales Quantity by Country (2021-2026) & (K Dose)
Table 115. Europe Anti-androgen Drugs Sales Quantity by Country (2027-2032) & (K Dose)
Table 116. Europe Anti-androgen Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 117. Europe Anti-androgen Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 118. Asia-Pacific Anti-androgen Drugs Sales Quantity by Type (2021-2026) & (K Dose)
Table 119. Asia-Pacific Anti-androgen Drugs Sales Quantity by Type (2027-2032) & (K Dose)
Table 120. Asia-Pacific Anti-androgen Drugs Sales Quantity by Application (2021-2026) & (K Dose)
Table 121. Asia-Pacific Anti-androgen Drugs Sales Quantity by Application (2027-2032) & (K Dose)
Table 122. Asia-Pacific Anti-androgen Drugs Sales Quantity by Region (2021-2026) & (K Dose)
Table 123. Asia-Pacific Anti-androgen Drugs Sales Quantity by Region (2027-2032) & (K Dose)
Table 124. Asia-Pacific Anti-androgen Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 125. Asia-Pacific Anti-androgen Drugs Consumption Value by Region (2027-2032) & (USD Million)
Table 126. South America Anti-androgen Drugs Sales Quantity by Type (2021-2026) & (K Dose)
Table 127. South America Anti-androgen Drugs Sales Quantity by Type (2027-2032) & (K Dose)
Table 128. South America Anti-androgen Drugs Sales Quantity by Application (2021-2026) & (K Dose)
Table 129. South America Anti-androgen Drugs Sales Quantity by Application (2027-2032) & (K Dose)
Table 130. South America Anti-androgen Drugs Sales Quantity by Country (2021-2026) & (K Dose)
Table 131. South America Anti-androgen Drugs Sales Quantity by Country (2027-2032) & (K Dose)
Table 132. South America Anti-androgen Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 133. South America Anti-androgen Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 134. Middle East & Africa Anti-androgen Drugs Sales Quantity by Type (2021-2026) & (K Dose)
Table 135. Middle East & Africa Anti-androgen Drugs Sales Quantity by Type (2027-2032) & (K Dose)
Table 136. Middle East & Africa Anti-androgen Drugs Sales Quantity by Application (2021-2026) & (K Dose)
Table 137. Middle East & Africa Anti-androgen Drugs Sales Quantity by Application (2027-2032) & (K Dose)
Table 138. Middle East & Africa Anti-androgen Drugs Sales Quantity by Country (2021-2026) & (K Dose)
Table 139. Middle East & Africa Anti-androgen Drugs Sales Quantity by Country (2027-2032) & (K Dose)
Table 140. Middle East & Africa Anti-androgen Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 141. Middle East & Africa Anti-androgen Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 142. Anti-androgen Drugs Raw Material
Table 143. Key Manufacturers of Anti-androgen Drugs Raw Materials
Table 144. Anti-androgen Drugs Typical Distributors
Table 145. Anti-androgen Drugs Typical Customers
Table 1. Global Anti-androgen Drugs Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Anti-androgen Drugs Consumption Value by Generation, (USD Million), 2021 & 2025 & 2032
Table 3. Global Anti-androgen Drugs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 4. Astellas Basic Information, Manufacturing Base and Competitors
Table 5. Astellas Major Business
Table 6. Astellas Anti-androgen Drugs Product and Services
Table 7. Astellas Anti-androgen Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 8. Astellas Recent Developments/Updates
Table 9. Pfizer Basic Information, Manufacturing Base and Competitors
Table 10. Pfizer Major Business
Table 11. Pfizer Anti-androgen Drugs Product and Services
Table 12. Pfizer Anti-androgen Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 13. Pfizer Recent Developments/Updates
Table 14. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 15. Johnson & Johnson Major Business
Table 16. Johnson & Johnson Anti-androgen Drugs Product and Services
Table 17. Johnson & Johnson Anti-androgen Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 18. Johnson & Johnson Recent Developments/Updates
Table 19. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 20. Bayer AG Major Business
Table 21. Bayer AG Anti-androgen Drugs Product and Services
Table 22. Bayer AG Anti-androgen Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. Bayer AG Recent Developments/Updates
Table 24. Orion Basic Information, Manufacturing Base and Competitors
Table 25. Orion Major Business
Table 26. Orion Anti-androgen Drugs Product and Services
Table 27. Orion Anti-androgen Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Orion Recent Developments/Updates
Table 29. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 30. Teva Pharmaceutical Major Business
Table 31. Teva Pharmaceutical Anti-androgen Drugs Product and Services
Table 32. Teva Pharmaceutical Anti-androgen Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. Teva Pharmaceutical Recent Developments/Updates
Table 34. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 35. Sun Pharmaceutical Major Business
Table 36. Sun Pharmaceutical Anti-androgen Drugs Product and Services
Table 37. Sun Pharmaceutical Anti-androgen Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Sun Pharmaceutical Recent Developments/Updates
Table 39. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 40. Dr. Reddy's Laboratories Major Business
Table 41. Dr. Reddy's Laboratories Anti-androgen Drugs Product and Services
Table 42. Dr. Reddy's Laboratories Anti-androgen Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Dr. Reddy's Laboratories Recent Developments/Updates
Table 44. Cipla Basic Information, Manufacturing Base and Competitors
Table 45. Cipla Major Business
Table 46. Cipla Anti-androgen Drugs Product and Services
Table 47. Cipla Anti-androgen Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. Cipla Recent Developments/Updates
Table 49. Hengrui Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 50. Hengrui Pharmaceuticals Major Business
Table 51. Hengrui Pharmaceuticals Anti-androgen Drugs Product and Services
Table 52. Hengrui Pharmaceuticals Anti-androgen Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. Hengrui Pharmaceuticals Recent Developments/Updates
Table 54. Lonza Group Basic Information, Manufacturing Base and Competitors
Table 55. Lonza Group Major Business
Table 56. Lonza Group Anti-androgen Drugs Product and Services
Table 57. Lonza Group Anti-androgen Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 58. Lonza Group Recent Developments/Updates
Table 59. WuXi AppTec Basic Information, Manufacturing Base and Competitors
Table 60. WuXi AppTec Major Business
Table 61. WuXi AppTec Anti-androgen Drugs Product and Services
Table 62. WuXi AppTec Anti-androgen Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 63. WuXi AppTec Recent Developments/Updates
Table 64. Asymchem Laboratories Basic Information, Manufacturing Base and Competitors
Table 65. Asymchem Laboratories Major Business
Table 66. Asymchem Laboratories Anti-androgen Drugs Product and Services
Table 67. Asymchem Laboratories Anti-androgen Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 68. Asymchem Laboratories Recent Developments/Updates
Table 69. Catalent Basic Information, Manufacturing Base and Competitors
Table 70. Catalent Major Business
Table 71. Catalent Anti-androgen Drugs Product and Services
Table 72. Catalent Anti-androgen Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 73. Catalent Recent Developments/Updates
Table 74. Global Anti-androgen Drugs Sales Quantity by Manufacturer (2021-2026) & (K Dose)
Table 75. Global Anti-androgen Drugs Revenue by Manufacturer (2021-2026) & (USD Million)
Table 76. Global Anti-androgen Drugs Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 77. Market Position of Manufacturers in Anti-androgen Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 78. Head Office and Anti-androgen Drugs Production Site of Key Manufacturer
Table 79. Anti-androgen Drugs Market: Company Product Type Footprint
Table 80. Anti-androgen Drugs Market: Company Product Application Footprint
Table 81. Anti-androgen Drugs New Market Entrants and Barriers to Market Entry
Table 82. Anti-androgen Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 83. Global Anti-androgen Drugs Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 84. Global Anti-androgen Drugs Sales Quantity by Region (2021-2026) & (K Dose)
Table 85. Global Anti-androgen Drugs Sales Quantity by Region (2027-2032) & (K Dose)
Table 86. Global Anti-androgen Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 87. Global Anti-androgen Drugs Consumption Value by Region (2027-2032) & (USD Million)
Table 88. Global Anti-androgen Drugs Average Price by Region (2021-2026) & (US$/Dose)
Table 89. Global Anti-androgen Drugs Average Price by Region (2027-2032) & (US$/Dose)
Table 90. Global Anti-androgen Drugs Sales Quantity by Type (2021-2026) & (K Dose)
Table 91. Global Anti-androgen Drugs Sales Quantity by Type (2027-2032) & (K Dose)
Table 92. Global Anti-androgen Drugs Consumption Value by Type (2021-2026) & (USD Million)
Table 93. Global Anti-androgen Drugs Consumption Value by Type (2027-2032) & (USD Million)
Table 94. Global Anti-androgen Drugs Average Price by Type (2021-2026) & (US$/Dose)
Table 95. Global Anti-androgen Drugs Average Price by Type (2027-2032) & (US$/Dose)
Table 96. Global Anti-androgen Drugs Sales Quantity by Application (2021-2026) & (K Dose)
Table 97. Global Anti-androgen Drugs Sales Quantity by Application (2027-2032) & (K Dose)
Table 98. Global Anti-androgen Drugs Consumption Value by Application (2021-2026) & (USD Million)
Table 99. Global Anti-androgen Drugs Consumption Value by Application (2027-2032) & (USD Million)
Table 100. Global Anti-androgen Drugs Average Price by Application (2021-2026) & (US$/Dose)
Table 101. Global Anti-androgen Drugs Average Price by Application (2027-2032) & (US$/Dose)
Table 102. North America Anti-androgen Drugs Sales Quantity by Type (2021-2026) & (K Dose)
Table 103. North America Anti-androgen Drugs Sales Quantity by Type (2027-2032) & (K Dose)
Table 104. North America Anti-androgen Drugs Sales Quantity by Application (2021-2026) & (K Dose)
Table 105. North America Anti-androgen Drugs Sales Quantity by Application (2027-2032) & (K Dose)
Table 106. North America Anti-androgen Drugs Sales Quantity by Country (2021-2026) & (K Dose)
Table 107. North America Anti-androgen Drugs Sales Quantity by Country (2027-2032) & (K Dose)
Table 108. North America Anti-androgen Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 109. North America Anti-androgen Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 110. Europe Anti-androgen Drugs Sales Quantity by Type (2021-2026) & (K Dose)
Table 111. Europe Anti-androgen Drugs Sales Quantity by Type (2027-2032) & (K Dose)
Table 112. Europe Anti-androgen Drugs Sales Quantity by Application (2021-2026) & (K Dose)
Table 113. Europe Anti-androgen Drugs Sales Quantity by Application (2027-2032) & (K Dose)
Table 114. Europe Anti-androgen Drugs Sales Quantity by Country (2021-2026) & (K Dose)
Table 115. Europe Anti-androgen Drugs Sales Quantity by Country (2027-2032) & (K Dose)
Table 116. Europe Anti-androgen Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 117. Europe Anti-androgen Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 118. Asia-Pacific Anti-androgen Drugs Sales Quantity by Type (2021-2026) & (K Dose)
Table 119. Asia-Pacific Anti-androgen Drugs Sales Quantity by Type (2027-2032) & (K Dose)
Table 120. Asia-Pacific Anti-androgen Drugs Sales Quantity by Application (2021-2026) & (K Dose)
Table 121. Asia-Pacific Anti-androgen Drugs Sales Quantity by Application (2027-2032) & (K Dose)
Table 122. Asia-Pacific Anti-androgen Drugs Sales Quantity by Region (2021-2026) & (K Dose)
Table 123. Asia-Pacific Anti-androgen Drugs Sales Quantity by Region (2027-2032) & (K Dose)
Table 124. Asia-Pacific Anti-androgen Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 125. Asia-Pacific Anti-androgen Drugs Consumption Value by Region (2027-2032) & (USD Million)
Table 126. South America Anti-androgen Drugs Sales Quantity by Type (2021-2026) & (K Dose)
Table 127. South America Anti-androgen Drugs Sales Quantity by Type (2027-2032) & (K Dose)
Table 128. South America Anti-androgen Drugs Sales Quantity by Application (2021-2026) & (K Dose)
Table 129. South America Anti-androgen Drugs Sales Quantity by Application (2027-2032) & (K Dose)
Table 130. South America Anti-androgen Drugs Sales Quantity by Country (2021-2026) & (K Dose)
Table 131. South America Anti-androgen Drugs Sales Quantity by Country (2027-2032) & (K Dose)
Table 132. South America Anti-androgen Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 133. South America Anti-androgen Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 134. Middle East & Africa Anti-androgen Drugs Sales Quantity by Type (2021-2026) & (K Dose)
Table 135. Middle East & Africa Anti-androgen Drugs Sales Quantity by Type (2027-2032) & (K Dose)
Table 136. Middle East & Africa Anti-androgen Drugs Sales Quantity by Application (2021-2026) & (K Dose)
Table 137. Middle East & Africa Anti-androgen Drugs Sales Quantity by Application (2027-2032) & (K Dose)
Table 138. Middle East & Africa Anti-androgen Drugs Sales Quantity by Country (2021-2026) & (K Dose)
Table 139. Middle East & Africa Anti-androgen Drugs Sales Quantity by Country (2027-2032) & (K Dose)
Table 140. Middle East & Africa Anti-androgen Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 141. Middle East & Africa Anti-androgen Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 142. Anti-androgen Drugs Raw Material
Table 143. Key Manufacturers of Anti-androgen Drugs Raw Materials
Table 144. Anti-androgen Drugs Typical Distributors
Table 145. Anti-androgen Drugs Typical Customers
LIST OF FIGURES
Figure 1. Anti-androgen Drugs Picture
Figure 2. Global Anti-androgen Drugs Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Anti-androgen Drugs Revenue Market Share by Type in 2025
Figure 4. NSARIs Examples
Figure 5. SARIs Examples
Figure 6. ASIs Examples
Figure 7. Global Anti-androgen Drugs Revenue by Generation, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Anti-androgen Drugs Revenue Market Share by Generation in 2025
Figure 9. 1st Gen Examples
Figure 10. 2nd Gen Examples
Figure 11. Global Anti-androgen Drugs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 12. Global Anti-androgen Drugs Revenue Market Share by Application in 2025
Figure 13. nmCRPC Examples
Figure 14. mCRPC Examples
Figure 15. mHSPC Examples
Figure 16. Special Endocrine / Female Examples
Figure 17. Global Anti-androgen Drugs Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 18. Global Anti-androgen Drugs Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 19. Global Anti-androgen Drugs Sales Quantity (2021-2032) & (K Dose)
Figure 20. Global Anti-androgen Drugs Price (2021-2032) & (US$/Dose)
Figure 21. Global Anti-androgen Drugs Sales Quantity Market Share by Manufacturer in 2025
Figure 22. Global Anti-androgen Drugs Revenue Market Share by Manufacturer in 2025
Figure 23. Producer Shipments of Anti-androgen Drugs by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 24. Top 3 Anti-androgen Drugs Manufacturer (Revenue) Market Share in 2025
Figure 25. Top 6 Anti-androgen Drugs Manufacturer (Revenue) Market Share in 2025
Figure 26. Global Anti-androgen Drugs Sales Quantity Market Share by Region (2021-2032)
Figure 27. Global Anti-androgen Drugs Consumption Value Market Share by Region (2021-2032)
Figure 28. North America Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 29. Europe Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 30. Asia-Pacific Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 31. South America Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 32. Middle East & Africa Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 33. Global Anti-androgen Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 34. Global Anti-androgen Drugs Consumption Value Market Share by Type (2021-2032)
Figure 35. Global Anti-androgen Drugs Average Price by Type (2021-2032) & (US$/Dose)
Figure 36. Global Anti-androgen Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 37. Global Anti-androgen Drugs Revenue Market Share by Application (2021-2032)
Figure 38. Global Anti-androgen Drugs Average Price by Application (2021-2032) & (US$/Dose)
Figure 39. North America Anti-androgen Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 40. North America Anti-androgen Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 41. North America Anti-androgen Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 42. North America Anti-androgen Drugs Consumption Value Market Share by Country (2021-2032)
Figure 43. United States Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 44. Canada Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 45. Mexico Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 46. Europe Anti-androgen Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 47. Europe Anti-androgen Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 48. Europe Anti-androgen Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 49. Europe Anti-androgen Drugs Consumption Value Market Share by Country (2021-2032)
Figure 50. Germany Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 51. France Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 52. United Kingdom Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 53. Russia Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 54. Italy Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 55. Asia-Pacific Anti-androgen Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 56. Asia-Pacific Anti-androgen Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 57. Asia-Pacific Anti-androgen Drugs Sales Quantity Market Share by Region (2021-2032)
Figure 58. Asia-Pacific Anti-androgen Drugs Consumption Value Market Share by Region (2021-2032)
Figure 59. China Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 60. Japan Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 61. South Korea Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 62. India Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 63. Southeast Asia Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 64. Australia Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 65. South America Anti-androgen Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 66. South America Anti-androgen Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 67. South America Anti-androgen Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 68. South America Anti-androgen Drugs Consumption Value Market Share by Country (2021-2032)
Figure 69. Brazil Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 70. Argentina Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 71. Middle East & Africa Anti-androgen Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 72. Middle East & Africa Anti-androgen Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 73. Middle East & Africa Anti-androgen Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 74. Middle East & Africa Anti-androgen Drugs Consumption Value Market Share by Country (2021-2032)
Figure 75. Turkey Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 76. Egypt Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 77. Saudi Arabia Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 78. South Africa Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 79. Anti-androgen Drugs Market Drivers
Figure 80. Anti-androgen Drugs Market Restraints
Figure 81. Anti-androgen Drugs Market Trends
Figure 82. Porters Five Forces Analysis
Figure 83. Manufacturing Cost Structure Analysis of Anti-androgen Drugs in 2025
Figure 84. Manufacturing Process Analysis of Anti-androgen Drugs
Figure 85. Anti-androgen Drugs Industrial Chain
Figure 86. Sales Channel: Direct to End-User vs Distributors
Figure 87. Direct Channel Pros & Cons
Figure 88. Indirect Channel Pros & Cons
Figure 89. Methodology
Figure 90. Research Process and Data Source
Figure 1. Anti-androgen Drugs Picture
Figure 2. Global Anti-androgen Drugs Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Anti-androgen Drugs Revenue Market Share by Type in 2025
Figure 4. NSARIs Examples
Figure 5. SARIs Examples
Figure 6. ASIs Examples
Figure 7. Global Anti-androgen Drugs Revenue by Generation, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Anti-androgen Drugs Revenue Market Share by Generation in 2025
Figure 9. 1st Gen Examples
Figure 10. 2nd Gen Examples
Figure 11. Global Anti-androgen Drugs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 12. Global Anti-androgen Drugs Revenue Market Share by Application in 2025
Figure 13. nmCRPC Examples
Figure 14. mCRPC Examples
Figure 15. mHSPC Examples
Figure 16. Special Endocrine / Female Examples
Figure 17. Global Anti-androgen Drugs Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 18. Global Anti-androgen Drugs Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 19. Global Anti-androgen Drugs Sales Quantity (2021-2032) & (K Dose)
Figure 20. Global Anti-androgen Drugs Price (2021-2032) & (US$/Dose)
Figure 21. Global Anti-androgen Drugs Sales Quantity Market Share by Manufacturer in 2025
Figure 22. Global Anti-androgen Drugs Revenue Market Share by Manufacturer in 2025
Figure 23. Producer Shipments of Anti-androgen Drugs by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 24. Top 3 Anti-androgen Drugs Manufacturer (Revenue) Market Share in 2025
Figure 25. Top 6 Anti-androgen Drugs Manufacturer (Revenue) Market Share in 2025
Figure 26. Global Anti-androgen Drugs Sales Quantity Market Share by Region (2021-2032)
Figure 27. Global Anti-androgen Drugs Consumption Value Market Share by Region (2021-2032)
Figure 28. North America Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 29. Europe Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 30. Asia-Pacific Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 31. South America Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 32. Middle East & Africa Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 33. Global Anti-androgen Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 34. Global Anti-androgen Drugs Consumption Value Market Share by Type (2021-2032)
Figure 35. Global Anti-androgen Drugs Average Price by Type (2021-2032) & (US$/Dose)
Figure 36. Global Anti-androgen Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 37. Global Anti-androgen Drugs Revenue Market Share by Application (2021-2032)
Figure 38. Global Anti-androgen Drugs Average Price by Application (2021-2032) & (US$/Dose)
Figure 39. North America Anti-androgen Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 40. North America Anti-androgen Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 41. North America Anti-androgen Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 42. North America Anti-androgen Drugs Consumption Value Market Share by Country (2021-2032)
Figure 43. United States Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 44. Canada Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 45. Mexico Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 46. Europe Anti-androgen Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 47. Europe Anti-androgen Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 48. Europe Anti-androgen Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 49. Europe Anti-androgen Drugs Consumption Value Market Share by Country (2021-2032)
Figure 50. Germany Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 51. France Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 52. United Kingdom Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 53. Russia Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 54. Italy Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 55. Asia-Pacific Anti-androgen Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 56. Asia-Pacific Anti-androgen Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 57. Asia-Pacific Anti-androgen Drugs Sales Quantity Market Share by Region (2021-2032)
Figure 58. Asia-Pacific Anti-androgen Drugs Consumption Value Market Share by Region (2021-2032)
Figure 59. China Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 60. Japan Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 61. South Korea Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 62. India Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 63. Southeast Asia Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 64. Australia Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 65. South America Anti-androgen Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 66. South America Anti-androgen Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 67. South America Anti-androgen Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 68. South America Anti-androgen Drugs Consumption Value Market Share by Country (2021-2032)
Figure 69. Brazil Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 70. Argentina Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 71. Middle East & Africa Anti-androgen Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 72. Middle East & Africa Anti-androgen Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 73. Middle East & Africa Anti-androgen Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 74. Middle East & Africa Anti-androgen Drugs Consumption Value Market Share by Country (2021-2032)
Figure 75. Turkey Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 76. Egypt Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 77. Saudi Arabia Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 78. South Africa Anti-androgen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 79. Anti-androgen Drugs Market Drivers
Figure 80. Anti-androgen Drugs Market Restraints
Figure 81. Anti-androgen Drugs Market Trends
Figure 82. Porters Five Forces Analysis
Figure 83. Manufacturing Cost Structure Analysis of Anti-androgen Drugs in 2025
Figure 84. Manufacturing Process Analysis of Anti-androgen Drugs
Figure 85. Anti-androgen Drugs Industrial Chain
Figure 86. Sales Channel: Direct to End-User vs Distributors
Figure 87. Direct Channel Pros & Cons
Figure 88. Indirect Channel Pros & Cons
Figure 89. Methodology
Figure 90. Research Process and Data Source
